Cognition in mouse models of schizophrenia susceptibility genes

Schizophrenia Bulletin

Volumn 36, Issue 2, 2010, Pages 289-300

  Arguello, P Alexander ^a   Gogos, Joseph A ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

22q11; CNTRICS; DISC1; Executive control; MATRICS; Working memory

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BUNGAROTOXIN RECEPTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DYSBINDIN; HAPTOGLOBIN; INTERLEUKIN 1BETA; NEUREXIN; PROTEIN KINASE B; PROTEIN P53; SEROTONIN 2A RECEPTOR; ZINC FINGER PROTEIN;

AFFECT; ATTENTION; BEHAVIOR; BRAIN FUNCTION; CHROMOSOME 10Q; CHROMOSOME 15Q; CHROMOSOME 16P; CHROMOSOME 17P; CHROMOSOME 22Q; CHROMOSOME TRANSLOCATION; COGNITION; COGNITIVE DEFECT; EXPERIMENTAL MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; LONG TERM MEMORY; NONHUMAN; PERCEPTION; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SOCIAL BEHAVIOR; WORKING MEMORY;

ALLELES; ANIMALS; BRAIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; EXECUTIVE FUNCTION; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMORY, SHORT-TERM; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 77749264373     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbp153     Document Type: Review

References (105)

1. Carter CS, et al. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry. 2008;64:4-10.
2. Hagan JJ, Jones DN. Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr Bull. 2005;31:830-853.
3. Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther. 2009;122:150-202.
4. Green MF, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004;56:301-307.
5. Cohen JD, Insel TR. Cognitive neuroscience and schizophrenia: translational research in need of a translator. Biol Psychiatry. 2008;64:2-3.
6. Dickinson D, Ragland JD, Gold JM, Gur RC. General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry. 2008;64:823-827.
7. Bilder RM, et al. Phenomics: the systematic study of pheno-types on a genome-wide scale. Neuroscience. 2009;164:30-42.
8. Nuechterlein KH, Robbins TW, Einat H. Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull. 2005;31:870-874.
9. Dickinson D, Gold JM. Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophr Bull. 2008;34:423-434.
10. Butcher LM, Kennedy JK, Plomin R. Generalist genes and cognitive neuroscience. Curr Opin Neurobiol. 2006;16:145-151.
11. MacDonald AW, III, et al. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am J Psychiatry. 2005;162:475-484.
12. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med. 2008;38:771-785.
13. Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:377-384.
14. Nakao T, et al. Working memory dysfunction in obsessive-compulsive disorder: a neuropsychological and functional MRI study. J Psychiatr Res. 2009;43:784-791.
15. Purcell SM, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
16. Sanders AR, et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry. 2008;165:497-506.
17. Need AC, et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 2009;5:e1000373.
18. Stefansson H, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744-747.
19. Shi J, et al. Common variants on chromosome 6p22. 1 are associated with schizophrenia. Nature. 2009;460:753-757.
20. Bodmer W, Bonilla C. Common and rare variants in multi-factorial susceptibility to common diseases. Nat Genet. 2008;40:695-701.
21. Todd JA. Statistical false positive or true disease pathway? Nat Genet. 2006;38:731-733.
22. ISC. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008;455:237-241.
23. Stefansson H, et al. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455:232-236.
24. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science. 2008;322:881-888.
25. St Clair D, et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 1990;336:13-16.
26. Karayiorgou M, et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA. 1995;92:7612-7616.
27. Xu B, et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet. 2008; 40:880-885.
28. McCarthy SE, et al. Microduplications of 16p11. 2 are associated with schizophrenia. Nat Genet. 2009;41:1223-1227.
29. Rujescu D, et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet. 2009;18:988-996.
30. Kirov G, et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 2009;18:1497-1503.
31. Arguello PA, Gogos JA. Modeling madness in mice: one piece at a time. Neuron. 2006;52:179-196.
32. Etherton MR, Blaiss CA, Powell CM, Sudhof TC. Mouse neurexin-1alpha deletion causes correlated electrophysiolog-ical and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci USA. 2009;106:17998-18003.
33. Young JW, et al. Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol. 2007;17:145-155.
34. Hikida T, et al. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA. 2007;104:14501-14506.
35. Pletnikov MV, et al. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry. 2008;13:115-173-186.
36. Li W, et al. Specific developmental disruption of disrupted-in- schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci USA. 2007;104: 18280-18285.
37. Clapcote SJ, et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron. 2007;54:387-402.
38. Koike H, Arguello PA, Kvajo M, Karayiorgou M, Gogos JA. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc Natl Acad Sci USA. 2006;103:3693-3697.
39. Kvajo M, et al. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neu-ronal architecture and cognition. Proc Natl Acad Sci USA. 2008;105:7076-7081.
40. Long JM, et al. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics. 2006;7:247-257.
41. Stark KL, et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet. 2008;40:751-760.
42. Javitt DC. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol. 2009;5:249-275.
43. Geyer MA, Braff DL. Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull. 1987;13:643-668.
44. Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA. 1996;93:11962-11967.
45. Butler PD, Silverstein SM, Dakin SC. Visual perception and its impairment in schizophrenia. Biol Psychiatry. 2008; 64:40-47.
46. Green MF, et al. Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS. Schizophr Bull. 2009;35:163-181.
47. Powell SB, Zhou X, Geyer MA. Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res. 2009;204:282-294.
48. Light GA, Braff DL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry. 2005;62:127-136.
49. Meyer D, Birchmeier C. Multiple essential functions of neu-regulin in development. Nature. 1995;378:386-390.
50. Ehrlichman RS, et al. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res. 2009;1294:116-127.
51. Adolphs R. The social brain: neural basis of social knowledge. Annu Rev Psychol. 2009;60:693-716.
52. Klin A, Lin DJ, Gorrindo P, Ramsay G, Jones W. Two-year-olds with autism orient to non-social contingencies rather than biological motion. Nature. 2009;459:257-261.
53. Sergi MJ, Rassovsky Y, Nuechterlein KH, Green MF. Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry. 2006;163:448-454.
54. Leitman DI, et al. The neural substrates of impaired pro-sodic detection in schizophrenia and its sensorial antecedents. Am J Psychiatry. 2007;164:474-482.
55. Carter CS, Barch DM, Gur R, Pinkham A, Ochsner K. CNTRICS final task selection: social cognitive and affective neuroscience-based measures. Schizophr Bull. 2009;35: 153-162.
56. Barch DM, Braver TS, Carter CS, Poldrack RA, Robbins TW. CNTRICS final task selection: executive control. Schizophr Bull. 2009;35:115-135.
57. Luck SJ, Gold JM. The construct of attention in schizophrenia. Biol Psychiatry. 2008;64:34-39.
58. Ragland JD, et al. CNTRICS final task selection: long-term memory. Schizophr Bull. 2009;35:197-212.
59. Barch DM, Smith E. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol Psychiatry. 2008;64:11-17.
60. Kerns JG, Nuechterlein KH, Braver TS, Barch DM. Executive functioning component mechanisms and schizophrenia. Biol Psychiatry. 2008;64:26-33.
61. Glickstein SB, Desteno DA, Hof PR, Schmauss C. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb Cortex. 2005;15:1016-1024.
62. De Steno DA, Schmauss C. A role for dopamine D2 receptors in reversal learning. Neuroscience. 2009;162:118-127.
63. Kruzich PJ, Mitchell SH, Younkin A, Grandy DK. Dopa-mine D2 receptors mediate reversal learning in male C57BL/6J mice. Cogn Affect Behav Neurosci. 2006;6:86-90.
64. Kruzich PJ, Grandy DK. Dopamine D2 receptors mediate two-odor discrimination and reversal learning in C57BL/6 mice. BMC Neurosci. 2004;5:12.
65. Papaleo F, et al. Genetic dissection of the role of catechol-O- methyltransferase in cognition and stress reactivity in mice. J Neurosci. 2008;28:8709-8723.
66. Leeson VC, et al. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry. 2009;66:586-593.
67. Krueger DD, et al. Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology. 2006;189: 95-104.
68. Helms CM, Gubner NR, Wilhelm CJ, Mitchell SH, Grandy DK. D4 receptor deficiency in mice has limited effects on impulsivity and novelty seeking. Pharmacol Biochem Behav. 2008;90:387-393.
69. Sarter M, Martinez V, Kozak R. A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology. 2009;202:237-258.
70. Jentsch JD, Arguello PA, Anzivino LA. Null mutation of the arginine-vasopressin gene in rats slows attentional engagement and facilitates response accuracy in a lateralized reaction time task. Neuropsychopharmacology. 2003;28: 1597-1605.
71. Ranganath C, Minzenberg MJ, Ragland JD. The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol Psychiatry. 2008;64:18-25.
72. Tang YP, et al. Genetic enhancement of learning and memory in mice. Nature. 1999;401:63-69.
73. von Engelhardt J, et al. Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks. Neuron. 2008;60: 846-860.
74. El-Ghundi M, et al. Spatial learning deficit in dopamine D(1) receptor knockout mice. Eur J Pharmacol. 1999;383: 95-106.
75. El-Ghundi M, O'Dowd BF, George SR. Prolonged fear responses in mice lacking dopamine D1 receptor. Brain Res. 2001;892:86-93.
76. Smith DR, et al. Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience. 1998;86:135-146.
77. Qiu S, et al. Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol Learn Mem. 2006;85:228-242.
78. Takao K, et al. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol Brain. 2008;1:11.
79. Bhardwaj SK, et al. Behavioral characterization of dysbindin-1 deficient sandy mice. Behav Brain Res. 2009;197:435-441.
80. Feng YQ, et al. Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia. Schizophr Res. 2008;106:218-228.
81. Maekawa M, Watanabe M, Yamaguchi S, Konno R, Hori Y. Spatial learning and long-term potentiation of mutant mice lacking D-amino-acid oxidase. Neurosci Res. 2005;53: 34-38.
82. Paylor R, et al. Mice deleted for the DiGeorge/velocardiofa-cial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum Mol Genet. 2001;10:2645-2650.
83. Kimber WL, et al. Deletion of 150 kb in the minimal DiGeorge/ velocardiofacial syndrome critical region in mouse. Hum Mol Genet. 1999;8:2229-2237.
84. Jonides J, et al. The mind and brain of short-term memory. Annu Rev Psychol. 2008;59:193-224.
85. Baddeley A. Working memory: looking back and looking forward. Nat Rev Neurosci. 2003;4:829-839.
86. Postle BR. Working memory as an emergent property of the mind and brain. Neuroscience. 2006;139:23-38.
87. Barch DM, et al. CNTRICS final task selection: working memory. Schizophr Bull. 2009;35:136-152.
88. Aultman JM, Moghaddam B. Distinct contributions of glu-tamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacology. 2001;153:353-364.
89. McNab F, Klingberg T. Prefrontal cortex and basal ganglia control access to working memory. Nat Neurosci. 2008;11:103-107.
90. Cannon TD, et al. Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. Arch Gen Psychiatry. 2005;62:1071-1080.
91. Grillet N, et al. Generation and characterization of Rgs4 mutant mice. Mol Cell Biol. 2005;25:4221-4228.
92. O'Tuathaigh CM, et al. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience. 2007;147:18-27.
93. Rimer M, Barrett DW, Maldonado MA, Vock VM, Gonzalez-Lima F. Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport. 2005;16:271-275.
94. Chen YJ, et al. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corti-costriatal circuit components. J Neurosci. 2008;28: 6872-6883.
95. Lai WS, et al. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci USA. 2006;103:16906-16911.
96. Glickstein SB, Hof PR, Schmauss C. Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits. J Neurosci. 2002;22:5619-5629.
97. Hartman RE, et al. Behavioral phenotyping of GFAP-apoE3 and-apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp Neurol. 2001;170:326-344.
98. Hsu R, et al. Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS One. 2007;2:e1234.
99. Budel S, et al. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci. 2008;28:13161-13172.
100. Paterlini M, et al. Transcriptional and behavioral interaction between 22q11. 2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci. 2005;8:1586-1594.
101. Snitz BE, Macdonald AW, III, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull. 2006;32:179-194.
102. Goos LM, Crosbie J, Payne S, Schachar R. Validation and extension of the endophenotype model in ADHD patterns of inheritance in a family study of inhibitory control. Am J Psychiatry. 2009;166:711-717.
103. Delorme R, et al. Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder. Eur Psychiatry. 2007;22:32-38.
104. Barch DM. The cognitive neuroscience of schizophrenia. Annu Rev Clin Psychol. 2005;1:321-353.
105. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007;64:532-542.